alzheimersdisease
A recent clinical trial has unveiled that intensive lifestyle modifications can significantly enhance cognition and daily functioning in patients with mild cognitive impairment or early dementia due to Alzheimer’s disease. Published in Alzheimer’s Research & Therapy, this multisite study is the first randomized controlled trial to demonstrate that non-drug interventions can offer substantial benefits to those already diagnosed with these conditions. Alzheimer’s disease is a progressive neurodegenerative disorder that primarily affects older adults, leading to the gradual loss of memory and cog...
PsyPost (UK)
A recent clinical trial has unveiled that intensive lifestyle modifications can significantly enhance cognition and daily functioning in patients with mild cognitive impairment or early dementia due to Alzheimer’s disease. Published in Alzheimer’s Research & Therapy, this multisite study is the first randomized controlled trial to demonstrate that non-drug interventions can offer substantial benefits to those already diagnosed with these conditions. Alzheimer’s disease is a progressive neurodegenerative disorder that primarily affects older adults, leading to the gradual loss of memory and cog...
PsyPost (CA)
A recent clinical trial has unveiled that intensive lifestyle modifications can significantly enhance cognition and daily functioning in patients with mild cognitive impairment or early dementia due to Alzheimer’s disease. Published in Alzheimer’s Research & Therapy, this multisite study is the first randomized controlled trial to demonstrate that non-drug interventions can offer substantial benefits to those already diagnosed with these conditions. Alzheimer’s disease is a progressive neurodegenerative disorder that primarily affects older adults, leading to the gradual loss of memory and cog...
PsyPost
Researchers in Germany have discovered that a combination of psychological factors and specific biological markers can help predict Alzheimer’s disease. By analyzing personality traits, depression and anxiety levels, genetic markers, and cerebrospinal fluid biomarkers, the study offers new insights into early detection. However, distinguishing between mild cognitive impairment and subjective cognitive decline remains challenging. Their study was published in the International Journal of Geriatric Psychiatry. As people age, their cognitive abilities often decline. Neural cells progressively die...
PsyPost (UK)
Researchers in Germany have discovered that a combination of psychological factors and specific biological markers can help predict Alzheimer’s disease. By analyzing personality traits, depression and anxiety levels, genetic markers, and cerebrospinal fluid biomarkers, the study offers new insights into early detection. However, distinguishing between mild cognitive impairment and subjective cognitive decline remains challenging. Their study was published in the International Journal of Geriatric Psychiatry. As people age, their cognitive abilities often decline. Neural cells progressively die...
PsyPost (CA)
Researchers in Germany have discovered that a combination of psychological factors and specific biological markers can help predict Alzheimer’s disease. By analyzing personality traits, depression and anxiety levels, genetic markers, and cerebrospinal fluid biomarkers, the study offers new insights into early detection. However, distinguishing between mild cognitive impairment and subjective cognitive decline remains challenging. Their study was published in the International Journal of Geriatric Psychiatry. As people age, their cognitive abilities often decline. Neural cells progressively die...
PsyPost
A recent study has revealed significant insights into the early brain changes associated with Alzheimer’s disease, focusing on volume loss in key brain regions. The researchers found that volume loss in the basal forebrain and hippocampus is more pronounced in individuals with high levels of amyloid-beta, a protein linked to Alzheimer’s, even before cognitive symptoms become apparent. The effect of amyloid-beta concentration on the pace of brain shrinkage (volume loss) varied between brain regions. The study was published in the Neurobiology of Aging. Amyloid-beta is a peptide that accumulates...
PsyPost (UK)
A recent study has revealed significant insights into the early brain changes associated with Alzheimer’s disease, focusing on volume loss in key brain regions. The researchers found that volume loss in the basal forebrain and hippocampus is more pronounced in individuals with high levels of amyloid-beta, a protein linked to Alzheimer’s, even before cognitive symptoms become apparent. The effect of amyloid-beta concentration on the pace of brain shrinkage (volume loss) varied between brain regions. The study was published in the Neurobiology of Aging. Amyloid-beta is a peptide that accumulates...
PsyPost (CA)
A recent study has revealed significant insights into the early brain changes associated with Alzheimer’s disease, focusing on volume loss in key brain regions. The researchers found that volume loss in the basal forebrain and hippocampus is more pronounced in individuals with high levels of amyloid-beta, a protein linked to Alzheimer’s, even before cognitive symptoms become apparent. The effect of amyloid-beta concentration on the pace of brain shrinkage (volume loss) varied between brain regions. The study was published in the Neurobiology of Aging. Amyloid-beta is a peptide that accumulates...
PsyPost
Scientists studying a family with early Alzheimer’s have found that some carry a genetic mutation that delays their initial symptoms. The hope is that this could help researchers find new ways of stopping the neurodegenerative disease if they can figure out how one copy of the very rare gene variant offers some protection. “It opens new avenues,” said Yakeel Quiroz, a neuropsychologist at Massachusetts General Hospital in the US, who helped lead the study published on Wednesday. “There are definitely opportunities to copy or mimic the effects.” Genetic protectionResearchers studying a family i...
Euronews (English)
閲覧を続けるには、ノアドット株式会社が「プライバシーポリシー」に定める「アクセスデータ」を取得することを含む「nor.利用規約」に同意する必要があります。
「これは何?」という方はこちら